A Phase II Clinical Study of HRS-7172 as Monotherapy or in Combination With Anti-Tumor Therapy in Participants With Advanced Lung Cancer to Evaluate Safety, Tolerability, and Efficacy (NCTNCT07950332) - Patient Guide & Enrollment Help